ROLE OF IL-6 IN EXPERIMENTAL ARTHRITIS CAUSED BY TRANSFER OF ARTHRITOGENIC ANTIBODIES

Interleukin-6 (IL-6) exerts important functions on immune regulation. In case of high expression, IL-6 may promote autoimmune disorders, e.g., arthritis. Systemic IL-6 blockers based on monoclonal antibodies against IL-6, or its specific receptor subunit, are already used in clinical settings, adding to a range of known biological drugs, such as, TNF blockers. Rheumatic disorders and their experimental therapy are reproducible in mice. This study revealed systemically increased levels of IL-6 in developing arthritis caused by transfer of pathogenic antibodies, as well as the effects of IL-6 neutralization by monoclonal antibodies against murine IL-6. Our results suggest a pathogenic role of the two cytokines, TNF and IL-6, in experimental arthritis induced by passive transfer of anti-collagen antibodies.

1. Друцкая М.С., Ефимов Г.А., Зварцев Р.В., Чащина А.А, Чудаков Д.М., Тиллиб С.В., Круглов А.А., Недоспасов С.А. Экспериментальные модели артрита для изучения действия блокаторов фактора некроза опухолей // Биохимия, 2014. Т. 79, № 12. С. 1647-1656. [Drutskaya M.S., Efimov G.A., Zvartsev R.V., Chashchina A.A., Chudakov D.M., Tillib S.V., Kruglov A.A., Nedospasov, S.A. Experim ental models of arthritis in which pathogenesis is dependent on TNF expression. Biokhimiya = Biochemistry, 2014 Vol. 79, no. 12, pp. 1349-1357. (In Russ.)]

2. Друцкая М.С., Носенко М.А., Атретханы К.-С.Н., Ефимов Г.А., Недоспасов С.А. Интерлейкин-6 – от молекулярных механизмов передачи сигнала к физиологическим функциям и терапевтическим мишеням. Молекулярная биология, 2015. Т. 49, № 6. C. 1-7. [Drutskaya M.S., Nosenko M.A., Atretkhany K.S., Efimov G.A., Nedospasov S.A. [Interleukin-6 From molecular mechanisms of signal transduction to physiological properties and therapeutic targeting]. Molekulyarnaya biologiya = Molecular Biology, 2015, Vol. 49, no. 6, pp. 937-943. (In Russ.)]

3. Bevaart L., Vervoordeldonk M.J., Tak P.P. Collagen-induced arthritis in mice. Methods in Molecular Biology, 2010, no. 602, pp. 181-192.

4. Brand D.D., Latham K.A., Rosloniec E.F. Collagen-induced arthritis. Nature Protocols, 2007, Vol. 2, no. 5, pp. 1269-1275.

5. Efimov G.A., Kruglov A.A., Khlopchatnikova Z.V., Rozov F.N., Mokhonov V.V., Rose-John S., Scheller J., Gordon S., Stacey M., Drutskaya M.S., Tillib S.V., Nedospasov S.A. Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source. Proceedings of the National Academy of Sciences USA, 2016, Vol. 113, pp. 3006-3011.

6. Fujimoto M., Serada S., Mihara M., Uchiyama Y., Yoshida H., Koike N., Ohsugi Y., Nishikawa T., Riple, B., Kimura A., Kishimoto T., Naka T. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheumatology, 2008, Vol. 58, no. 12, pp. 3710-3719.

7. Hutamekalin P., Saito T., Yamaki K., Mizutani N., Brand D.D., Waritani T., Terato K., Yoshino S. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies. Journal of Immunological Methods, 2009, Vol. 343, no. 1, pp. 49-55.

8. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., Kollias G. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO Journal, 1991, Vol. 10, no. 13, pp. 4025-4031.

9. Kuprash D.V., Tumanov A.V., Liepinsh D.J., Koroleva E.P., Drutskaya M.S., Kruglov A.A., Shakhov A.N., Southon E., Murphy W.J., Tessarollo L., Grivennikov S.I., Nedospasov S.A. Novel tumor necrosis factor-knockout mice that lack Peyer’s patches. European Journal of Immunology, 2005, Vol. 35, no. 5, pp. 1592-1600.

10. Lacey D., Hickey P., Arhatari B.D., O’Reilly L.A., Rohrbeck L., Kiriazis H., Du X.J., Bouillet P. Spontaneous retrotransposon insertion into TNF 3’UTR causes heart valve disease and chronic polyarthritis. Proceedings of the National Academy of Sciences USA, 2015, Vol. 112, no. 31, pp. 9698-9703.

11. Li X., Bradford B.U., Dalldorf F., Goyert S.M., Stimpson S.A., Thurman R.G., Makarov S.S. CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Gram-positive bacterial cell walls. Arthritis Research and Therapy, 2004, Vol. 6, no. 3, pp. R273-281.